awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38650502-129C2571-28D9-4E83-95BC-3A2CCFEA9291
Q38650502-129C2571-28D9-4E83-95BC-3A2CCFEA9291
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38650502-129C2571-28D9-4E83-95BC-3A2CCFEA9291
Oral versus intravenous fluoropyrimidines for colorectal cancer.
P2860
Q38650502-129C2571-28D9-4E83-95BC-3A2CCFEA9291
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38650502-129C2571-28D9-4E83-95BC-3A2CCFEA9291
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
88568b9c9a549de9255c6c91da9c14ff0230de92
P2860
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.